MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Henry Schein Inc

Open

SectorGezondheidszorg

65.17 -0.79

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

64.82

Max

66.41

Belangrijke statistieken

By Trading Economics

Inkomsten

-3M

96M

Verkoop

17M

3.2B

K/W

Sectorgemiddelde

20.682

57.333

EPS

1.19

Winstmarge

3.008

Werknemers

25,000

EBITDA

1M

237M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+19.28% upside

Dividenden

By Dow Jones

Volgende Winsten

5 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-2.4B

7.9B

Vorige openingsprijs

65.96

Vorige sluitingsprijs

65.17

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

Henry Schein Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

29 jan 2025, 13:28 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal

29 jan 2025, 14:04 UTC

Top Nieuws
Acquisities, Fusies, Overnames

KKR Builds Stake in Medical-Supply Company -- 2nd Update

29 jan 2025, 12:54 UTC

Acquisities, Fusies, Overnames

KKR Builds Stake in Medical-Supply Company -- Update

29 jan 2025, 12:07 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein Sees 2025 Adjusted Ebitda Up Mid-Single Digits >HSIC

29 jan 2025, 12:07 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein Sees 2025 Revenue Up Low- to Mid-Single Digits >HSIC

29 jan 2025, 12:06 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein: KKR Buying $250 Million in New Shares Based on Market Price >HSIC

29 jan 2025, 12:06 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein Sees 4Q Rev $3.2B >HSIC

29 jan 2025, 12:03 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein: KKR Representatives Max Lin, William Daniel to Join Board >HSIC

29 jan 2025, 12:03 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein: KKR Will Have Ability to Boost Stake to 14.9% via Open Market Purchases >HSIC

29 jan 2025, 12:02 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein Names Robert Hombach an Independent Director >HSIC

29 jan 2025, 12:02 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein Increases Share-Repurchase Program Authorization by $500 Million >HSIC

29 jan 2025, 12:02 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein Sees 2025 Adjusted EPS Up Low- to Mid-Single Digits >HSIC

29 jan 2025, 12:01 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein Sees 4Q Adj EPS $1.19 >HSIC

29 jan 2025, 12:00 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein, KKR to Collaborate Range of Value Creation Opportunities >HSIC

29 jan 2025, 12:00 UTC

Winsten
Acquisities, Fusies, Overnames

Henry Schein: KKR to Become 12% Common Shareholder >HSIC

29 jan 2025, 10:30 UTC

Top Nieuws
Acquisities, Fusies, Overnames

KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats -- WSJ

29 jan 2025, 10:30 UTC

Acquisities, Fusies, Overnames

Henry Schein Has Already Been an Activist Target -- WSJ

29 jan 2025, 10:30 UTC

Acquisities, Fusies, Overnames

Private-Equity Firm KKR to Work to Improve Operations at Medical and Dental Supplier, Sources Say -- WSJ

29 jan 2025, 10:30 UTC

Acquisities, Fusies, Overnames

KKR Has Taken a Big Stake in Henry Schein, Will Get Two Board Seats, Sources Say -- WSJ

Peer Vergelijking

Prijswijziging

Henry Schein Inc Prognose

Koersdoel

By TipRanks

19.28% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 79 USD  19.28%

Hoogste 90 USD

Laagste 55 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Henry Schein Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

12 ratings

4

Buy

7

Hold

1

Sell

Technische score

By Trading Central

64.73 / 66.92Steun & Weerstand

Korte Termijn

Very Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Strong Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Henry Schein Inc

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.